Medicare coverage is now offered!
Press release: August 1, 2023
Abbott has launched Freestyle Libre 3 reader in the U.S.
The people on Medicare now can also get the system covered. The Freestyle Libre 3 reader pairs with one of the best continuous glucose monitors (CGM) sensors. This device was cleared by the FDA last year.
The Freestyle Libre 3 reader received approval from the Food and Drug Administration (FDA) on April 14, 2023. Medicare mandates a separate reader for all approvals of Continuous Glucose Monitoring (CGM) systems. Great news for Freestyle Libre 3 users is that Medicare coverage for this device is available.
What is Freestyle Libre 3 reader?
The Freestyle Libre 3 reader is a handheld device that displays real-time glucose readings directly from a small sensor worn on the back of the person’s upper arm. It is FDA-clear for adults and children with no fingerstick.
Here are some of the features of the Freestyle Libre 3 reader:
Real-time glucose readings: The reader displays glucose readings every minute, so you can see how your blood sugar is changing in real time.
Trend arrows: The reader shows trend arrows that indicate whether your blood sugar is going up, down, or staying the same. This can help you predict future glucose levels and make adjustments to your treatment plan.
Time in range: The reader shows you how much time you spend in your target glucose range. This can help you track your progress and make sure you’re staying on track.
Alerts and alarms: The reader can send alerts and alarms if your blood sugar goes too high or too low. This can help you avoid dangerous blood sugar levels.
You can now buy Freestyle Libre 3 reader online from us with or without insurance coverage, as the reader is now available in the US.